Expert Review of Vaccines, Volume 21, Issue 6 (2022)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Review of Vaccines, Volume 21, Issue 6 (2022)

See all volumes and issues
Vol 23, 2024 Vol 22, 2023 Volume 21, 2022 Vol 20, 2021 Vol 19, 2020 Vol 18, 2019 Vol 17, 2018 Vol 16, 2017 Vol 15, 2016 Vol 14, 2015 Vol 13, 2014 Vol 12, 2013 Vol 11, 2012 Vol 10, 2011 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002
Download citations Download PDFs Download issue

Editorial

Editorial
In 30 years, gender-neutral vaccination eradicates oncogenic human papillomavirus (HPV) types while screening eliminates HPV-associated cancers
Matti Lehtinen, Penelope Gray, Karolina Louvanto & Simopekka Vänskä
Pages: 735-738
Published online: 15 Apr 2022
First Page PreviewforIn 30 years, gender-neutral vaccination eradicates oncogenic human papillomavirus (HPV) types while screening eliminates HPV-associated cancers | Full Text | References | PDF (1.5 MB) | EPUB
  • 2018 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access

Review

Correlates of protection for meningococcal surface protein vaccines: lessons from the past
Jamie Findlow, Jay Lucidarme, Muhamed-Kheir Taha, Cynthia Burman & Paul Balmer
Pages: 739-751
Published online: 21 Jul 2021
AbstractforCorrelates of protection for meningococcal surface protein vaccines: lessons from the past | Full Text | References | PDF (389.2 KB) | EPUB
  • 3356 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access
Correlates of protection for meningococcal surface protein vaccines: current approaches for the determination of breadth of coverage
Jamie Findlow, Ray Borrow, David S. Stephens, Paul Liberator, Annaliesa S. Anderson, Paul Balmer & Luis Jodar
Pages: 753-769
Published online: 10 Jun 2022
AbstractforCorrelates of protection for meningococcal surface protein vaccines: current approaches for the determination of breadth of coverage | Full Text | References | PDF (556.3 KB) | EPUB
  • 1462 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Chlamydia trachomatis: quest for an eye-opening vaccine breakthrough
Vivek P Chavda, Anjali Pandya, Erica Kypreos, Vandana Patravale & Vasso Apostolopoulos
Pages: 771-781
Published online: 26 Apr 2022
AbstractforChlamydia trachomatis: quest for an eye-opening vaccine breakthrough | Full Text | References | PDF (1.8 MB) | EPUB
  • 480 Views
  • 2 CrossRef citations
  • 0Altmetric
Progress Towards a Therapeutic HIV DNA Vaccine
Paul Munson
Pages: 783-798
Published online: 06 Apr 2022
AbstractforProgress Towards a Therapeutic HIV DNA Vaccine | Full Text | References | PDF (3.5 MB) | EPUB
  • 644 Views
  • 3 CrossRef citations
  • 0Altmetric
Ensuring quality and integrity of vaccines throughout the cold chain: the role of temperature monitoring
Umit Kartoglu & Henry Ames
Pages: 799-810
Published online: 08 Apr 2022
AbstractforEnsuring quality and integrity of vaccines throughout the cold chain: the role of temperature monitoring | Full Text | References | PDF (594.8 KB) | EPUB
  • 4791 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access
Thermostable vaccines: an innovative concept in vaccine development
Ravinder Kumar, Vartika Srivastava, Piyush Baindara & Aijaz Ahmad
Pages: 811-824
Published online: 11 Apr 2022
AbstractforThermostable vaccines: an innovative concept in vaccine development | Full Text | References | PDF (3.1 MB) | EPUB
  • 850 Views
  • 9 CrossRef citations
  • 0Altmetric
Current status of COVID-19 vaccination: safety and liability concern for children, pregnant and lactating women
Swagat Kumar Das, Manish Paul, Bikash Chandra Behera & Hrudayanath Thatoi
Pages: 825-842
Published online: 04 Apr 2022
AbstractforCurrent status of COVID-19 vaccination: safety and liability concern for children, pregnant and lactating women | Full Text | References | PDF (2.3 MB) | EPUB
  • 258 Views
  • 2 CrossRef citations
  • 0Altmetric

Meta-analysis

Global prevalence of acceptance of COVID-19 vaccines and associated factors in pregnant women: a systematic review and meta-analysis
Maryam Nikpour, Mahdi Sepidarkish, Shabnam Omidvar & Mojgan Firouzbakht
Pages: 843-851
Published online: 22 Mar 2022
AbstractforGlobal prevalence of acceptance of COVID-19 vaccines and associated factors in pregnant women: a systematic review and meta-analysis | Full Text | References | PDF (1.8 MB) | EPUB
  • 305 Views
  • 10 CrossRef citations
  • 0Altmetric

Original Research

Article
Vaccination coverage rates and attitudes towards mandatory vaccinations among healthcare personnel in tertiary-care hospitals in Greece
Helena C. Maltezou, Maria Tseroni, Ioannis Drositis, Maria N. Gamaletsou, Dimitra Maria Koukou, Emmanouil Bolikas, Emmanuela Peskelidou, Charalambos Daflos, Evangelia Panagiotaki, Caterina Ledda, Androula Pavli, Nikolaos Moussas, Stavroula Kontogianni, Eftychia Svarna, Michalis Ploumidis, Andronikos Spyrou, Maria Chini, Georgios Adamis, Athanasia Lourida, Dimitrios Hatzigeorgiou, Panagiotis Gargalianos, George Syrogiannopoulos & Nikolaos V. Sipsas
Pages: 853-859
Published online: 13 Apr 2022
AbstractforVaccination coverage rates and attitudes towards mandatory vaccinations among healthcare personnel in tertiary-care hospitals in Greece | Full Text | References | PDF (958.1 KB) | EPUB
  • 237 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Immunogenicity and safety of 4 intramuscular standard-dose and high-dose hepatitis B vaccine in people living with HIV: a randomized, parallel-controlled trial
Yongliang Feng, Zhuanzhuan Chen, Ruixue Xie, Tian Yao, Yuanting Wu, Feng Yang, Chenli Yuan, Xiaoyong Nie, Fuzhen Wang, Xiaofeng Liang & Suping Wang
Pages: 861-868
Published online: 01 Apr 2022
AbstractforImmunogenicity and safety of 4 intramuscular standard-dose and high-dose hepatitis B vaccine in people living with HIV: a randomized, parallel-controlled trial | Full Text | References | PDF (1.1 MB) | EPUB
  • 191 Views
  • 0 CrossRef citations
  • 0Altmetric

Letter to the Editor

Response to Vyse et al., “A review of current data to support decision making for introduction of next generation higher valency pneumococcal conjugate vaccination of immunocompetent older adults in the UK”
Rachel Dawson, Ulrike K. Buchwald, Kelly D. Johnson & Laura Spowart
Pages: 869-870
Published online: 22 Mar 2022
CitationforResponse to Vyse et al., “A review of current data to support decision making for introduction of next generation higher valency pneumococcal conjugate vaccination of immunocompetent older adults in the UK” | Full Text | References | PDF (124.7 KB) | EPUB
  • 1156 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Response to Dawson et al: Letter to the Editor on ‘‘A review of current data to support decision making for introduction of next generation higher valency pneumococcal conjugate vaccination of immunocompetent older adults in the UK’’
Andrew Vyse, James Campling, Carole Czudek, Gillian Ellsbury, Diana Mendes, Ralf-René Reinert & Mary P.E. Slack
Pages: 871-872
Published online: 08 Mar 2022
CitationforResponse to Dawson et al: Letter to the Editor on ‘‘A review of current data to support decision making for introduction of next generation higher valency pneumococcal conjugate vaccination of immunocompetent older adults in the UK’’ | Full Text | References | PDF (112.4 KB) | EPUB
  • 1175 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

Economic evaluation of second measles containing vaccine (MCV) dose: a systematic review of available evidence
Samuel Bawa et al.
Review Article | Published online: 26 Jun 2024
Open Access
Mapping and ranking outcomes for the evaluation of seasonal influenza vaccine efficacy and effectiveness: a delphi study
Chiara de Waure et al.
Article | Published online: 25 Jun 2024
Open Access
Immune mechanisms targeting malaria transmission: opportunities for vaccine development
Geetha P. Bansal et al.
Review Article | Published online: 25 Jun 2024
Open Access
Antibody persistence and revaccination recommendations of MenACWY-TT: a review of clinical studies assessing antibody persistence up to 10 years after vaccination
Cynthia Burman et al.
Review Article | Published online: 7 Jun 2024
Open Access